Investigative journalist Katherine Eban set out to report on a seemingly straightforward question: Are generic drugs really identical to their brand-name counterparts? The answer sparked a decade of interviews, meetings with whistleblowers, on-the-ground reporting across four continents and digging into confidential FDA documents. In this alarming talk, she takes us inside overseas manufacturing plants and exposes the fraud behind many low-cost generic medicines.